Inspire Investing, LLC Xencor Inc Transaction History

Inspire Investing, LLC

  • $858 Million
  • Q4 2024

A detailed history of Inspire Investing, LLC transactions in Xencor Inc stock. As of the latest transaction made, Inspire Investing, LLC holds 17,489 shares of XNCR stock, worth $361,497. This represents 0.05% of its overall portfolio holdings.

Number of Shares
17,489
Previous 20,530 14.81%
Holding current value
$361,497
Previous $412,000 2.67%
% of portfolio
0.05%
Previous 0.04%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 17, 2025
SELL
$19.43 - $26.84 $59,086 - $81,620
-3,041 Reduced 14.81%
17,489 $401,000
Q3 2024

Oct 10, 2024
BUY
$15.7 - $21.65 $29,625 - $40,853
1,887 Added 10.12%
20,530 $412,000
Q2 2024

Aug 12, 2024
BUY
$18.21 - $24.5 $46,672 - $62,793
2,563 Added 15.94%
18,643 $352,000
Q1 2024

May 07, 2024
SELL
$18.65 - $26.52 $43,491 - $61,844
-2,332 Reduced 12.67%
16,080 $355,000
Q4 2023

Feb 12, 2024
BUY
$16.53 - $21.42 $51,970 - $67,344
3,144 Added 20.59%
18,412 $390,000
Q3 2023

Oct 26, 2023
BUY
$20.08 - $25.39 $306,581 - $387,654
15,268 New
15,268 $307,000
Q2 2020

Aug 12, 2020
SELL
$27.76 - $33.42 $333 - $401
-12 Closed
0 $0
Q1 2020

May 08, 2020
BUY
$20.69 - $37.79 $248 - $453
12 New
12 $0
Q1 2018

Apr 13, 2018
SELL
$21.18 - $33.78 $1,101 - $1,756
-52 Closed
0 $0
Q4 2017

Feb 15, 2018
BUY
$19.29 - $24.83 $1,003 - $1,291
52
52 $1,000

Others Institutions Holding XNCR

# of Institutions
216
Shares Held
71.5M
Call Options Held
2.5K
Put Options Held
7.9K
View Full List

About Xencor Inc

XNCR Quotes by TradingView
  • Ticker XNCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,698,100
  • Market Cap $1.23B
  • Description
  • Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...
More about XNCR
Track This Portfolio

Track Inspire Investing, LLC Portfolio

Follow Inspire Investing, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Inspire Investing, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Inspire Investing, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email